Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin®], enoxaparin [Lovenox®]) and factor Xa inhibitors (fondaparinux [Arixtra®]). In the last several years, global market of injectable anticoagulants developed slowly. In 2016, global revenue of injectable anticoagulants is nearly 5300 M USD. And the global growth rate is slow.
The classification of injectable anticoagulants includes LMWH, DTI and other, and the proportion of LMWH in 2016 is about 55%, and the proportion is in decreasing trend from 2012 to 2016.Injectable anticoagulants are widely used for VTE, ACS/MI, AF and other field. The most proportion of injectable anticoagulants used to treat AF, and the revenue in 2016 is 3400 M USD.
This report elaborates on the current development of the Injectable Anticoagulants industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Genentech (Roche)
Boehringer Ingelheim
Aspen
Otsuka
Sanofi
Pfizer
By Type:
Direct Thrombin Inhibitor (DTI)
Other
Low-molecular-weight Heparin (LMWH)
By Application:
AF
VTE
Other
ACS/MI
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Injectable Anticoagulants Market Overview 2018-2029
-
1.1 China Injectable Anticoagulants Industry Development Overview
-
1.2 China Injectable Anticoagulants Industry Development History
-
1.3 China Injectable Anticoagulants Industry Market Size (2018-2029)
-
1.4 China Injectable Anticoagulants Market Analysis by Type from Production Side
-
1.4.1 China Injectable Anticoagulants Production Volume, Production Value and Growth Rate of Direct Thrombin Inhibitor (DTI) (2018-2029)
-
1.4.2 China Injectable Anticoagulants Production Volume, Production Value and Growth Rate of Other (2018-2029)
-
1.4.3 China Injectable Anticoagulants Production Volume, Production Value and Growth Rate of Low-molecular-weight Heparin (LMWH) (2018-2029)
-
1.5 China Injectable Anticoagulants Market Analysis by Application from Consumption End
-
1.5.1 China Injectable Anticoagulants Sales Volume, Sales Value and Growth Rate of AF (2018-2029)
-
1.5.2 China Injectable Anticoagulants Sales Volume, Sales Value and Growth Rate of VTE (2018-2029)
-
1.5.3 China Injectable Anticoagulants Sales Volume, Sales Value and Growth Rate of Other (2018-2029)
-
1.5.4 China Injectable Anticoagulants Sales Volume, Sales Value and Growth Rate of ACS/MI (2018-2029)
-
1.6 China Injectable Anticoagulants Market Analysis by Region
-
1.6.1 North China Injectable Anticoagulants Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Injectable Anticoagulants Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Injectable Anticoagulants Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Injectable Anticoagulants Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Injectable Anticoagulants Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Injectable Anticoagulants Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Injectable Anticoagulants Market Size and Growth Rate from 2018-2029
Chapter 2 China Injectable Anticoagulants Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Injectable Anticoagulants Market Status and Competition at home and abroad in 2023
-
2.2.2 China Injectable Anticoagulants Market Status and Competition Analysis in 2023
-
2.2.3 China Injectable Anticoagulants Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Injectable Anticoagulants Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Injectable Anticoagulants Industry Development
Chapter 3 Injectable AnticoagulantsIndustry Chain Analysis
-
3.1 Injectable Anticoagulants Industry Chain
-
3.2 Injectable Anticoagulants Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Injectable Anticoagulants Market
-
3.3 Injectable Anticoagulants Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Injectable Anticoagulants Market
Chapter 4 China Injectable Anticoagulants Market, by Type
-
4.1 China Injectable Anticoagulants Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Injectable Anticoagulants Total Production Volume and Growth Rate from Production Side
-
4.5 China Injectable Anticoagulants Production Volume and Growth Rate, by Type
-
4.5.1 China Injectable Anticoagulants Production Volume and Growth Rate of Direct Thrombin Inhibitor (DTI)
-
4.5.2 China Injectable Anticoagulants Production Volume and Growth Rate of Other
-
4.5.3 China Injectable Anticoagulants Production Volume and Growth Rate of Low-molecular-weight Heparin (LMWH)
Chapter 5 China Injectable Anticoagulants Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Injectable Anticoagulants Total Market Size and Growth Rate from Consumption End
-
5.5 China Injectable Anticoagulants Market Size and Growth Rate, by Application
-
5.5.1 China Injectable Anticoagulants Market Size and Growth Rate of AF
-
5.5.2 China Injectable Anticoagulants Market Size and Growth Rate of VTE
-
5.5.3 China Injectable Anticoagulants Market Size and Growth Rate of Other
-
5.5.4 China Injectable Anticoagulants Market Size and Growth Rate of ACS/MI
Chapter 6 China Injectable Anticoagulants Market, by Region
-
6.1 China Injectable Anticoagulants Production Volume and Production Value, by Region
-
6.2 China Injectable Anticoagulants Sales Volume and Sales Value, by Region
Chapter 7 North China Injectable Anticoagulants Market Analysis
-
7.1 North China Injectable Anticoagulants Market, by Type
-
7.2 North China Injectable Anticoagulants Market, by Application
Chapter 8 Central China Injectable Anticoagulants Market Analysis
-
8.1 Central China Injectable Anticoagulants Market, by Type
-
8.2 Central China Injectable Anticoagulants Market, by Application
Chapter 9 South China Injectable Anticoagulants Market Analysis
-
9.1 South China Injectable Anticoagulants Market, by Type
-
9.2 South China Injectable Anticoagulants Market, by Application
Chapter 10 East China Injectable Anticoagulants Market Analysis
-
10.1 East China Injectable Anticoagulants Market, by Type
-
10.2 East China Injectable Anticoagulants Market, by Application
Chapter 11 Northeast China Injectable Anticoagulants Market Analysis
-
11.1 Northeast China Injectable Anticoagulants Market, by Type
-
11.2 Northeast China Injectable Anticoagulants Market, by Application
Chapter 12 Southwest China Injectable Anticoagulants Market Analysis
-
12.1 Southwest China Injectable Anticoagulants Market, by Type
-
12.2 Southwest China Injectable Anticoagulants Market, by Application
Chapter 13 Northwest China Injectable Anticoagulants Market Analysis
-
13.1 Northwest China Injectable Anticoagulants Market, by Type
-
13.2 Northwest China Injectable Anticoagulants Market, by Application
Chapter 14 Company Profiles
-
14.1 Genentech (Roche)
-
14.1.1 Genentech (Roche) Company Profile
-
14.1.2 Genentech (Roche) Injectable Anticoagulants Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Boehringer Ingelheim
-
14.2.1 Boehringer Ingelheim Company Profile
-
14.2.2 Boehringer Ingelheim Injectable Anticoagulants Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Aspen
-
14.3.1 Aspen Company Profile
-
14.3.2 Aspen Injectable Anticoagulants Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Otsuka
-
14.4.1 Otsuka Company Profile
-
14.4.2 Otsuka Injectable Anticoagulants Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Sanofi
-
14.5.1 Sanofi Company Profile
-
14.5.2 Sanofi Injectable Anticoagulants Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Pfizer
-
14.6.1 Pfizer Company Profile
-
14.6.2 Pfizer Injectable Anticoagulants Market Performance
-
14.6.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Injectable Anticoagulants Industry Research Conclusions
-
15.2 Injectable Anticoagulants Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Injectable Anticoagulants Industry Market Size (2018-2029)
-
Figure China Injectable Anticoagulants Production Volume, Production Value and Growth Rate of Direct Thrombin Inhibitor (DTI) (2018-2029)
-
Figure China Injectable Anticoagulants Production Volume, Production Value and Growth Rate of Other (2018-2029)
-
Figure China Injectable Anticoagulants Production Volume, Production Value and Growth Rate of Low-molecular-weight Heparin (LMWH) (2018-2029)
-
Figure China Injectable Anticoagulants Sales Volume, Sales Value and Growth Rate of AF (2018-2029)
-
Figure China Injectable Anticoagulants Sales Volume, Sales Value and Growth Rate of VTE (2018-2029)
-
Figure China Injectable Anticoagulants Sales Volume, Sales Value and Growth Rate of Other (2018-2029)
-
Figure China Injectable Anticoagulants Sales Volume, Sales Value and Growth Rate of ACS/MI (2018-2029)
-
Figure North China Injectable Anticoagulants Market Size and Growth Rate from 2018-2029
-
Figure Central China Injectable Anticoagulants Market Size and Growth Rate from 2018-2029
-
Figure South China Injectable Anticoagulants Market Size and Growth Rate from 2018-2029
-
Figure East China Injectable Anticoagulants Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Injectable Anticoagulants Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Injectable Anticoagulants Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Injectable Anticoagulants Market Size and Growth Rate from 2018-2029
-
Figure Injectable Anticoagulants Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Injectable Anticoagulants Market Share by Type in 2018
-
Figure China Injectable Anticoagulants Market Share by Type in 2023
-
Figure China Injectable Anticoagulants Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Injectable Anticoagulants Production Volume and Growth Rate of Direct Thrombin Inhibitor (DTI) (2018-2023)
-
Figure China Injectable Anticoagulants Production Volume and Growth Rate of Other (2018-2023)
-
Figure China Injectable Anticoagulants Production Volume and Growth Rate of Low-molecular-weight Heparin (LMWH) (2018-2023)
-
Figure China Injectable Anticoagulants Market Share by Application in 2018
-
Figure China Injectable Anticoagulants Market Share by Application in 2023
-
Figure China Injectable Anticoagulants Total Market Size and Growth Rate from Consumption End
-
Figure China Injectable Anticoagulants Market Size and Growth Rate of AF (2018-2023)
-
Figure China Injectable Anticoagulants Market Size and Growth Rate of VTE (2018-2023)
-
Figure China Injectable Anticoagulants Market Size and Growth Rate of Other (2018-2023)
-
Figure China Injectable Anticoagulants Market Size and Growth Rate of ACS/MI (2018-2023)
-
Table China Injectable Anticoagulants Production Volume by Region (2018-2023)
-
Table China Injectable Anticoagulants Production Volume Share by Region (2018-2023)
-
Figure China Injectable Anticoagulants Production Volume Share by Region (2018-2023)
-
Table China Injectable Anticoagulants Production Value by Region (2018-2023)
-
Table China Injectable Anticoagulants Production Value Share by Region (2018-2023)
-
Figure China Injectable Anticoagulants Production Value Share by Region (2018-2023)
-
Table China Injectable Anticoagulants Sales Volume by Region (2018-2023)
-
Table China Injectable Anticoagulants Sales Volume Share by Region (2018-2023)
-
Figure China Injectable Anticoagulants Sales Volume Share by Region (2018-2023)
-
Table China Injectable Anticoagulants Sales Value by Region (2018-2023)
-
Table China Injectable Anticoagulants Sales Value Share by Region (2018-2023)
-
Figure China Injectable Anticoagulants Sales Value Share by Region (2018-2023)
-
Table North China Injectable Anticoagulants Production Volume by Type (2018-2023)
-
Table North China Injectable Anticoagulants Production Volume Share by Type (2018-2023)
-
Figure North China Injectable Anticoagulants Production Volume Share by Type (2018-2023)
-
Table North China Injectable Anticoagulants Sales Volume by Application (2018-2023)
-
Table North China Injectable Anticoagulants Sales Volume Share by Application (2018-2023)
-
Figure North China Injectable Anticoagulants Sales Volume Share by Application (2018-2023)
-
Table Central China Injectable Anticoagulants Production Volume by Type (2018-2023)
-
Table Central China Injectable Anticoagulants Production Volume Share by Type (2018-2023)
-
Figure Central China Injectable Anticoagulants Production Volume Share by Type (2018-2023)
-
Table Central China Injectable Anticoagulants Sales Volume by Application (2018-2023)
-
Table Central China Injectable Anticoagulants Sales Volume Share by Application (2018-2023)
-
Figure Central China Injectable Anticoagulants Sales Volume Share by Application (2018-2023)
-
Table South China Injectable Anticoagulants Production Volume by Type (2018-2023)
-
Table South China Injectable Anticoagulants Production Volume Share by Type (2018-2023)
-
Figure South China Injectable Anticoagulants Production Volume Share by Type (2018-2023)
-
Table South China Injectable Anticoagulants Sales Volume by Application (2018-2023)
-
Table South China Injectable Anticoagulants Sales Volume Share by Application (2018-2023)
-
Figure South China Injectable Anticoagulants Sales Volume Share by Application (2018-2023)
-
Table East China Injectable Anticoagulants Production Volume by Type (2018-2023)
-
Table East China Injectable Anticoagulants Production Volume Share by Type (2018-2023)
-
Figure East China Injectable Anticoagulants Production Volume Share by Type (2018-2023)
-
Table East China Injectable Anticoagulants Sales Volume by Application (2018-2023)
-
Table East China Injectable Anticoagulants Sales Volume Share by Application (2018-2023)
-
Figure East China Injectable Anticoagulants Sales Volume Share by Application (2018-2023)
-
Table Northeast China Injectable Anticoagulants Production Volume by Type (2018-2023)
-
Table Northeast China Injectable Anticoagulants Production Volume Share by Type (2018-2023)
-
Figure Northeast China Injectable Anticoagulants Production Volume Share by Type (2018-2023)
-
Table Northeast China Injectable Anticoagulants Sales Volume by Application (2018-2023)
-
Table Northeast China Injectable Anticoagulants Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Injectable Anticoagulants Sales Volume Share by Application (2018-2023)
-
Table Southwest China Injectable Anticoagulants Production Volume by Type (2018-2023)
-
Table Southwest China Injectable Anticoagulants Production Volume Share by Type (2018-2023)
-
Figure Southwest China Injectable Anticoagulants Production Volume Share by Type (2018-2023)
-
Table Southwest China Injectable Anticoagulants Sales Volume by Application (2018-2023)
-
Table Southwest China Injectable Anticoagulants Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Injectable Anticoagulants Sales Volume Share by Application (2018-2023)
-
Table Northwest China Injectable Anticoagulants Production Volume by Type (2018-2023)
-
Table Northwest China Injectable Anticoagulants Production Volume Share by Type (2018-2023)
-
Figure Northwest China Injectable Anticoagulants Production Volume Share by Type (2018-2023)
-
Table Northwest China Injectable Anticoagulants Sales Volume by Application (2018-2023)
-
Table Northwest China Injectable Anticoagulants Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Injectable Anticoagulants Sales Volume Share by Application (2018-2023)
-
Table Genentech (Roche) Company Profile
-
Table Genentech (Roche) Injectable Anticoagulants Revenue, Price and Gross (2018-2023)
-
Table Boehringer Ingelheim Company Profile
-
Table Boehringer Ingelheim Injectable Anticoagulants Revenue, Price and Gross (2018-2023)
-
Table Aspen Company Profile
-
Table Aspen Injectable Anticoagulants Revenue, Price and Gross (2018-2023)
-
Table Otsuka Company Profile
-
Table Otsuka Injectable Anticoagulants Revenue, Price and Gross (2018-2023)
-
Table Sanofi Company Profile
-
Table Sanofi Injectable Anticoagulants Revenue, Price and Gross (2018-2023)
-
Table Pfizer Company Profile
-
Table Pfizer Injectable Anticoagulants Revenue, Price and Gross (2018-2023)
-
